Cardiovascular Systems, Inc.
CSII · NASDAQ
6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | |
|---|---|---|---|---|
| Market Cap | $563 | $1,656 | $1,081 | $1,438 |
| - Cash | $66 | $71 | $185 | $74 |
| + Debt | $20 | $21 | $21 | $21 |
| Enterprise Value | $517 | $1,606 | $917 | $1,384 |
| Revenue | $236 | $259 | $237 | $248 |
| % Growth | -8.8% | 9.5% | -4.6% | – |
| Gross Profit | $173 | $198 | $188 | $200 |
| % Margin | 73.1% | 76.4% | 79.4% | 80.8% |
| EBITDA | -$34 | -$10 | -$24 | $5 |
| % Margin | -14.2% | -3.9% | -10.1% | 2% |
| Net Income | -$37 | -$13 | -$27 | -$0 |
| % Margin | -15.6% | -5.2% | -11.5% | -0.1% |
| EPS Diluted | -0.94 | -0.35 | -0.79 | -0.008 |
| % Growth | -168.6% | 55.7% | -10,294.7% | – |
| Operating Cash Flow | -$24 | -$1 | -$13 | $10 |
| Capital Expenditures | -$4 | -$4 | -$4 | -$4 |
| Free Cash Flow | -$28 | -$5 | -$17 | $7 |